Cargando…
Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology
Safety, quality, and regulatory-driven iterative optimization of therapeutic cell source selection has constituted the core developmental bedrock for primary fetal progenitor cell (FPC) therapy in Switzerland throughout three decades. Customized Fetal Transplantation Programs were pragmatically devi...
Autores principales: | Laurent, Alexis, Hirt-Burri, Nathalie, Scaletta, Corinne, Michetti, Murielle, de Buys Roessingh, Anthony S., Raffoul, Wassim, Applegate, Lee Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644790/ https://www.ncbi.nlm.nih.gov/pubmed/33195124 http://dx.doi.org/10.3389/fbioe.2020.557758 |
Ejemplares similares
-
Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine
por: Laurent, Alexis, et al.
Publicado: (2021) -
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care
por: Laurent, Alexis, et al.
Publicado: (2023) -
Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine
por: Laurent, Alexis, et al.
Publicado: (2021) -
Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds
por: Laurent, Alexis, et al.
Publicado: (2020) -
Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland
por: Laurent, Alexis, et al.
Publicado: (2021)